Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 0 | 0 | 0 | 0 | 19 |
| Cost of Goods | N/A | N/A | N/A | N/A | 12 |
| Gross Profit | N/A | N/A | N/A | N/A | 7 |
| Operating Expenses | 713 | 956 | 1,439 | 1,548 | 1,546 |
| Operating Income | -713 | -956 | -1,439 | -1,548 | -1,527 |
| Interest Expense | 29 | 29 | 0 | 0 | 0 |
| Other Income | -700 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,442 | -985 | -1,439 | -1,548 | -1,527 |
| Net Income Continuous | -1,442 | -985 | -1,439 | -1,548 | -1,527 |
| Net Income Discontinuous | N/A | N/A | N/A | -1,218 | -242 |
| Net Income | $-1,442 | $-985 | $-1,439 | $-2,765 | $-1,769 |
| EPS Basic Total Ops | -0.12 | -0.09 | -0.16 | -0.33 | -0.28 |
| EPS Basic Continuous Ops | -0.12 | -0.09 | -0.16 | -0.15 | -0.25 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.18 | -0.03 |
| EPS Diluted Total Ops | -0.12 | -0.09 | -0.16 | -0.33 | -0.28 |
| EPS Diluted Continuous Ops | -0.12 | -0.09 | -0.16 | -0.15 | -0.25 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.18 | -0.03 |
| EBITDA(a) | $-710 | $-953 | $-1,435 | $-1,527 | $-1,436 |